| Hans-Günter Meyer-Thompson | Neue Psychoaktive Substanzen
Europa. Report on the risk assessment of N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) in the framework of the Council Decision on new psychoactive substances
EMCDDA. Report on the risk assessment of N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) in the framework of the Council Decision on new psychoactive substances
(EMCDDA,Lissabon,Mai 2018)
http://www.emcdda.europa.eu/publications/risk-assessments/adb-chminaca_en